|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Serelaxin,recombinant human relaxin-2,for treatment of acute heart failure(RELAX-AHF):a randomised,placebo-controlled trial显示文摘 | Teerlink JR Cotter G Davison BA | | 0，，9860： | 1 |
| 2 | Effect of serelaxin on cardiac,renal,and hepatic biomarkers in the Relaxin in Acute Heart Failure(RELAX-AHF)development program:correlation with outcomes显示文摘 | Metra M Cotter G Davison BA | | 0，，02： | 1 |
| 3 | Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF) : a randomised, placebo-controlled trial显示文摘 | TeerlinkJR Cotter G Davison BA | 2013 | Lancet2013，381，9860： | 1 |
| 4 | Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes显示文摘 | Metra M Cotter G Davison BA | 2013 | J Am Coll Cardiol2013，61，2： | 1 |
| 5 | Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond显示文摘 | Cotter G Milo O Davison BA | 2014 | Curt Heart Fail Rep2014，1，1： | 1 |
| 6 | Regionalisation of Land Surface Hydrological Model Parameters in Subarctic and Arctic Environments显示文摘 | Domes PF Tolson BA Davison B | 2008 | Physics and Chemistry of the Earth2008，33，1718： | 1 |
| 7 | Efect of serelaxin on cardiac,renal,and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program:correlation with outcomes显示文摘 | Metra M Cotter G Davison BA | 2013 | J Am Coll Carliol2013，61，2： | 1 |
| 8 | Effect of serelaxin on cardiac, renal,and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AI-IF) development program :correlation with outcomes 显示文摘 | Metra M Cotter G Davison BA | 2013 | J Am Coil Cardiol2013，61，2： | 1 |
| 9 | Serelaxin,re-combinant human relaxin-2,for treatment of acute heart failure(RELAX-AHF):a randomised,placebo-controlled trial显示文摘 | Teerlink JR Cotter G Davison BA | | 0，，9860： | 1 |
| 10 | Serelaxin reeombiant human relaxin- 2, for treatment of acute heart failure (RELAX-AHF) : a randomised, placeo trial显示文摘 | Teerlink JR Cotter G Davison BA | 2013 | Lancet2013，381，9860： | 1 |
| 11 | Effect of serelaxin on cardiac,renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes显示文摘 | Metra M Cotter G Davison BA | 2013 | J AmColl Cardiol2013，61，2： | 1 |
| 12 | Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial 显示文摘 | Teerlink JR Cotter G Davison BA | 2013 | Lancet2013，381，9860： | 1 |
| 13 | Serelaxin,recombinant human relaxin-2,for treatment of acute heart failure (RELAX-AHF):a randomised,placebo-controlled trial显示文摘 | Teerlink JR Cotter G Davison BA | 2013 | Lancet2013，381，9860： | 1 |
| 14 | Effect of serelaxin on cardiac,renal,and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program:correlation with outcomes显示文摘 | Metra M Cotter G Davison BA | 2013 | J Am Coll Cardiol2013，61，2： | 1 |
| 15 | Serelaxin, recombinant human relaxin-2 ,for treatment of acute heart failure(RELAX-AHF) :A random- ised,placebo-controlled trial显示文摘 | Yeerlink JR Cotter G Davison BA | 2013 | Lancet2013，381，9860： | 1 |
| 16 | Increased mortality after an acute heart failure episode:new pathophysiological insights from the RELAX-AHF study and beyond显示文摘 | Cotter G Milo O Davison BA | 2014 | Curr Heart Fail Rep2014，11，1： | 1 |
| 17 | Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX AHF) : a randomized, placebo-controlled trial 显示文摘 | Teerlink JR Cotter G Davison BA | 2013 | Lancet2013，381，9860： | 1 |
| 18 | Serelaxin,recombinant human relaxin-2,for treatment of acute heart failure (RE-LAXAHF):a randomised,placebo-controlled trial显示文摘 | Teerlink JR Cotter G Davison BA | | 0，，： | 1 |
| 19 | Relaxin in Acute Heart Failure (RELAX-AHF) Investigators Serelaxin, re- combinant human relaxin-2, for treatment of acute heart fail- ure (RELAX-AHF): a randomised, placebo-controlled trial 显示文摘 | Teerlink JR Cotter G Davison BA | 2013 | Lancet2013，381，9860： | 1 |
| 20 | Effect of serelaxin on cardiac,renal,and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program:correlation with outcomes显示文摘 | Metra M Cotter G Davison BA | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员